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imm.ox.ac.uk (P.C. Simister), stephan.feller@imm.ox.aThe molecular architectures of intracellular signaling networks are largely unknown. Understand-
ing their design principles and mechanisms of processing information is essential to grasp the
molecular basis of virtually all biological processes. This is particularly challenging for human
pathologies like cancers, as essentially each tumor is a unique disease with vastly deranged signal-
ing networks. However, even in normal cells we know almost nothing. A few ‘signalosomes’, like the
COP9 and the TCR signaling complexes have been described, but detailed structural information on
their architectures is largely lacking. Similarly, many growth factor receptors, for example EGF
receptor, insulin receptor and c-Met, signal via huge protein complexes built on large platform pro-
teins (Gab, Irs/Dok, p130Cas[BCAR1], Frs families etc.), which are structurally not well understood.
Subsequent higher order processing events remain even more enigmatic. We discuss here methods
that can be employed to study signaling architectures, and the importance of too often neglected
features like macromolecular crowding, intrinsic disorder in proteins and the sophisticated cellular
infrastructures, which need to be carefully considered in order to develop a more mature under-
standing of cellular signal processing.
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Albert Einstein (1879–1955)1. Introduction
Representations of signaling networks in many textbooks and
even in some of the most recent review articles have in their sim-
plicity a striking similarity to children’s drawings. This is no acci-
dent: our level of sophistication when it comes to understanding
cell signaling network architectures is rather limited.
Two common types of current signaling data display methods
are the ‘furball’ for protein–protein interaction data and the
‘dumpling soup’ for signaling pathways and networks (Fig. 1).
These schematic representations do not take into account the
many layers of complexity that inﬂuence a myriad of signaling pro-
cesses, which will ﬁnally funnel into seemingly simple cell deci-
sions about their survival, growth, proliferation, migration or
differentiation.
There are many reasons for the current lack of better models.
On a technical level, methods that are at our disposal may com-
monly not be adequate for the task. Signaling molecules are often
low in abundance [1] and their interactions can be highly transient
[2]. This makes the endogenously expressed protein molecules
hard to study with available techniques. Over-expression studies,B.V. Open access under CC BY-NC-ND license. 
Fig. 1. (A) Example of a signaling protein ‘furball’ representing the numerous physical interactions of the p53 tumor suppressor protein (based on information from the
BioGRID database [171] displayed in Cytoscape 2.8.2 [172]. (B) Growth factor receptor-initiated signaling depicted as a ‘dumpling soup’.
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duce profound artifacts in terms of aberrant protein localization, as
well as spill-over effects in other parts of cellular signaling net-
works. Epitope tags that are frequently used to mark exogenously
expressed proteins can also fundamentally change the molecular
behaviors of proteins.
We also simply do not understand yet many of the relevant
structures of signaling architectures and we lack knowledge about
some complex variables that govern signaling networks [3]. To
overcome these limitations, new concepts need to be put forward
and must then be rigorously scrutinized with sufﬁciently sophisti-
cated experimentation.
Protein functions are frequently controlled through their associ-
ations with other proteins, which inﬂuence their activities and
localizations. Groups of proteins often form functional assemblies
or even large (megadalton-sized) ‘signalosomes’ in which the indi-
vidual protein components fulﬁll highly speciﬁc tasks. The term
‘signalosome’ was possibly ﬁrst used in the context of the COP9
multi-protein complex, a widely conserved and multi-functional
cellular ‘machine’ that was initially discovered in plants, where it
is regulated by light signals [4–9]. More recently other signalo-
somes have been proposed including the T cell receptor signalo-
some [10–12], the Wnt signalosome [13] and the adhesion
signalosome [14,15]. Many more can be expected to emerge in
the next years. Signalosomes are not at all tightly ﬁxed in their
composition and hence their architectures, and they can vary in
size considerably depending on their signaling state [13].
Owing to their considerable dimensions and the ‘zip codes’
encoded in their components, signalosomes are expected to fre-
quently inhabit distinct subcellular locations, sometimes also called
‘microdomains’, which further deﬁne their actions and functions.
The same proteins, or different splice variants thereof, can therefore
appear in several distinct sub-cellular compartments and engage in
very different types of activities [16,17]. Many aspects of this
cellular organization are still unknown. In recent years we have
learned a lot about direct protein–protein interactions but relatively
little about how these translate into higher-order protein com-
plexes or sub-cellular compartmentalization. To see a more com-
plete picture it is important to understand how this higher order
of organization can ﬁne-tune the functions of individual proteins.
We argue here that it will be necessary to thoroughly examine
signaling protein functions in the context of the architectures of
the multi-protein complexes in which they are incorporated and
also the infrastructures provided by the cellular environment. We
will touch on some of the methods that may help to further eluci-
date the architectures of such complexes and their networks.2. Intracellular signal processing largely depends on protein
complexes
Small secondary messengers, like phosphatidylinositols, cAMP,
Ca2+ or NO, cannot carry a large amount of information and have
to rely largely on random diffusion to reach their intended destina-
tion. They can transfer broad messages, often at a high speed. How-
ever, complex signals and signal processing are typically left to
proteins.
A human cell will at any given time express a large contingent
of the 22300 or more proteins that are encoded in the human gen-
ome [18] and several thousand of these are signaling proteins. Hu-
mans have around 800 G protein-coupled receptors, over 500
protein kinases and an as yet uncounted but vast number of pro-
teins that form speciﬁc complexes in response to post-translational
protein modiﬁcations like phosphorylation, acetylation and ubiq-
uitinylation [19–25], with many of them being involved in signal-
ing processes. According to the RESID database, there exist morethan 500 types of modiﬁcation (www.ebi.ac.uk/RESID/). To match
some of these, numerous ‘ﬂavors’ of specialized ‘reader’ domains
that recognize the modiﬁcations have evolved ([26]; see also EMBL
database SMART). The founding family of these domains are the
SH2 domains, which boast over 120 human members and are
essential for the recognition of speciﬁc protein surface epitopes
that contain phosphotyrosine residues ([26–28]; see also SH2
binding sites in Fig. 2). Unlike small secondary messengers, some
proteins, especially signaling proteins, are often expressed in low
numbers per cell [1] and their movements are substantially
restricted by the overwhelming presence of other large
biomolecules.
3. The impact of macromolecular crowding on signaling
processes
Cells comprise extremely densely packed environments. The
intracellular concentration of proteins has been estimated at
around 200–300 mg/ml for mammalian cells [29] with macromol-
ecules occupying up to 40% of the total cell volume [30]. The high
concentrations of macromolecules are not limited to the cell inte-
rior but occur also in the extracellular matrix [31].
It is not the high concentration of a single species of macromol-
ecule but the multitude of different macromolecules in a small vol-
ume that, through steric repulsion, hinders molecular diffusion and
can have a profound effect on protein function and association.
Hence, molecular crowding [32,33] is a key factor that shapes the
molecular arrangement of cellular signaling networks.
Macromolecular crowding has several consequences for protein
movement and function: it can strongly reduce the distance a pro-
tein travels (up to 100 times [31]). It can also promote the associ-
ation of proteins. Equilibrium constants for macromolecular
associations can be increased by several orders of magnitude
[31,33]. This may help to explain why even apparently low afﬁnity
interactions, measured in aqueous solutions, may be sufﬁcient for
some biologically important protein–protein interactions [2,34]. It
is one of the major challenges in the investigation of protein–pro-
tein interactions to distinguish between these functional and non-
functional weak interactions.
Macromolecular crowding can also directly affect protein struc-
ture and function. In a recent example, Dhar et al. demonstrate ma-
jor conformational changes of phosphoglycerate kinase and an
over 15-fold increase in its viscosity-adjusted enzymatic activity
under crowded conditions [35]. Two further reports suggest a role
for molecular crowding in the kinetics of Erk phosphorylation
[36,37]. Crowding forces a rapid re-association of MAPK/Erk kinase
(MEK) and its Erk substrate in a process that mimics processive
phosphorylation [38,39].
The effects of crowding are rarely considered in biochemical
experiments and concentrations of macromolecules in biochemi-
cal assays often do not exceed 10 mg/ml [40]. As there is no
simple way to mimic or manipulate intracellular crowding
conditions, crowding effects are studied by the addition of
reagents that simulate steric but not other intra-cellular interac-
tions in in vitro experiments [40,41]. The lack of more advanced
methods to assess crowding in an in vivo setting has so far made
it difﬁcult to study its effects on macromolecular assemblies in a
systematic way.
4. Cellular infrastructure: localized protein expression and
directional transport
Despite being restricted by macromolecular crowding, diffusion
clearly plays a signiﬁcant part in protein-mediated signaling.
Morphogens that deﬁne cell polarity in the Drosophila egg are a
Fig. 2. Human Gab1 protein in the traditional stick representation and as a graphic display of its presumed signal computation architecture according to the N-terminal
folding nucleation (NFN) hypothesis. (A) ‘Classical’ stick representation of human Gab1. The N-terminal phospholipid (PIP3)-binding pleckstrin homology (PH) domain is
drawn as a colored ribbon structure. The ribbon representation of PDB 2X18 used here was created in UCSF Chimera 1.6 [173]. Known target sites for Gab1 phosphorylation
by protein kinases (Y, Ser) are also shown. Tyrosine (Y) residues are color coded according to their presumed interactions with different SH2 domain containing proteins (see
also boxed explanations of symbols). These follow site-speciﬁc Y phosphorylations by kinases like c-Met, Src and Abl. Two short helical structural elements identiﬁed through
crystallographic studies are known binding sites for the C-terminal SH3 domain of the adaptor protein Grb2 [163] and couple Gab1 to various receptor proteins [104]. Serine
551 in humans (corresponding to S552 in mouse) is the target residue for phosphorylation by Erk1/2. Serine 551 phosphorylation has been proposed to disrupt the interaction
of this epitope with the Gab1 PH domain, which opens up the Gab1 PH domain PIP3 binding site and allows Gab1 translocation to the membrane [162]. Predicted secondary
structure elements at the C-terminus of Gab1 [161] are shown as a purple arrow and an orange cylinder. (B) Schematic representation of the proposed Gab1 signal
computation architecture. Gab family proteins and their relatives (the p130Cas[BCAR1], Irs/Dok and Frs families) are large multi-site docking (LMD) proteins that are
intensely studied and known to serve as assembly platforms for multi-protein complexes (signalosomes) which process signals from a wide range of transmembrane
receptors as well as cytoplasmic kinases [100–104]. They are expected to function as molecular computation machines that integrate information from multiple ‘input’
kinases and subsequently produce coordinated output signals that steer biological cell actions. These cell actions, for example cell survival, proliferation, migration or
invasion, need to be well orchestrated to avoid ‘conﬂicts of interest’, e.g. between the assembly of the mitotic spindle during cell division and cytoskeletal changes during
migratory processes. The LMD protein kinases (e.g. EGFR, ErbB2, IGFR, c-Met, Src, Abl, Erk etc.) provide information about a large number of environmental and intrinsic
conditions by phosphorylating, or not, one or more deﬁned epitopes of the LMD protein tails, thereby determining whether a cell is to die, to live, to divide or to migrate. Most
of the known phosphorylation sites (see www.phosphosite.org for more information) are found in proposed loop regions of the protein tails. These tail loops are suspected to
form co-translationally during the emergence of the nascent protein chains from the ribosomes [143]. The N-terminal regions of the LMD proteins mentioned above contain
one or two well-folded domains (PH, SH3, PTB), which form spontaneously and then could serve as ‘nucleation cores’ for the emerging protein tails that are several hundred
amino acids in length. The ﬁrst in vitro and in vivo evidence for interactions between the Gab1 PH domain and the Gab1 tail has been reported [143,162]. The architectural
model shown here could explain how LMD protein tails, which were previously thought to be unstructured, may serve as organized but still dynamic platforms for an
effective signal computation in cells. Although this model goes beyond traditional ‘dumpling’ or ‘stick’ representations of disordered proteins, it is still an oversimpliﬁcation
and would need further reﬁnement to accommodate all existing and newly emerging data. Note that the actual tail-interacting residues on the surface of the Gab1 PH domain
have not yet been deﬁned. (C) Simple functional diagram of signal processing via the Gab1 LMD protein platform.
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tein diffusion [42,43]. Other pathways may depend on some com-
ponent that diffuses freely, like STAT1 in the interferon-c response
pathway [44]. However, large signaling complexes contain a huge
number of individual components which may not be very highly
expressed. Random diffusion of these components, restricted by
macromolecular crowding and cellular compartmentalization,
would be a very unreliable and error-prone process for their
assembly. It is therefore very likely that in many cases the forma-
tion of protein complexes is actively supported by the cellular
transport infrastructure.
Even in prokaryotic cells diffusion may be only one way of pro-
tein distribution. Prokaryotes, sometimes wrongly considered to belittle more than semi-permeable protein ‘bags’, actually show a
high degree of spatial organization. Many of their macromolecules
accumulate at speciﬁc locations where they fulﬁll their biochemi-
cal and physiological functions [45].
The spatial regulation of mRNA translation is one of the mech-
anisms that can coordinate protein localization in cells [46,47].
Site-speciﬁc and hence asymmetric mRNA localization was ﬁrst
observed for b-actin mRNA in ascidian embryos [48]. Recently tar-
geting of mRNA was also shown in Escherichia coli, challenging the
view of coupled transcription and translation in prokaryotes [49].
In mammals, mRNA localization has been observed and exten-
sively researched in nerve cells with their often very long exten-
sions [50]. Beyond that, it was also found to be an important
2744 M. Lewitzky et al. / FEBS Letters 586 (2012) 2740–2750factor in ontogeny. Heterogenous distribution of Cdx2 mRNA
establishes cell polarity in the early mouse embryo [51]. This is,
according to very recent results, mediated by a 97 bp region pre-
ceding the Cdx2 mRNA 3’UTR (30 untranslated region), which is
responsible for the mRNA localization (Magdalena Zernicka-Goetz,
personal communication).
This method of spatial regulation of protein expression may be
very common. More than 70% of mRNAs of 3370 genes analyzed
were asymmetrically expressed in Drosophila [52]. The ﬁrst sys-
tematic investigation of mRNA localization in mammalian cells
found that more than 50 species of mRNA preferentially accumu-
late in the cellular protrusions of migrating mouse NIH3T3 ﬁbro-
blasts [53].
Site-speciﬁc mRNA localization can be achieved by local degra-
dation or stabilization, by anchoring at the translation site or by
active transport [54]. Active transport relies on localization sig-
nals, zip codes, in the mRNA sequence. These zip codes are recog-
nized by speciﬁc binding proteins that regulate active transport
along the cytoskeleton [55,56]. mRNAs are transported along
microtubules and actin ﬁlaments, often in granules containing
ribosomal proteins. In neurons their speed has been measured
at 0.1 lm/s [57]. At the endpoint of their journey, translation
can be initiated by local signaling events [58]. This has been dem-
onstrated for the b-actin mRNA in zip code-binding protein 1
(ZBP1)-containing granules where phosphorylation of ZBP1 by
the tyrosine kinase Src at the cell periphery induces actin mRNA
translation [59].
Active localization of mRNA may be one way to allocate compo-
nents of signaling complexes to a speciﬁc location in cell. However,
sharing the same system of kinesin super-family protein motors
running on cytoskeletal tracks, protein complexes, vesicles or even
complete organelles like mitochondria can be actively transported
[60]. In fact, most newly synthesized proteins are actively trans-
ported to their appropriate destinations [61]. Although kinesin
molecules can bind their cargo directly, they typically interact with
their cargo through adapter or scaffold proteins like ADAP1 [62],
DISC1 [63], GRIP1 [64], JIP1 [65] and Mint1 [66]. Unloading is con-
trolled here too by local signaling events and can be triggered by
phosphorylation, Rab GTPase activity and Ca2+ signaling [67]. Scaf-
fold proteins recognized by kinesin modules are often also in-
volved in signaling pathways, suggesting that kinesin motors can
transport pre-assembled signaling modules to speciﬁc locations
[68]. This is no more clearly demonstrated than for the JNK-inter-
acting protein 1 (JIP1) scaffold which is transported preloaded with
the upstream kinase DLK and the trans-membrane receptor
ApoER2 [69], or for Mint1 which is transported in a complex with
its up- and down-stream interaction partners CASK, MALS and a
NR2B receptor subunit [66].
5. Cell membrane properties and microdomains contribute to
organizing signaling complex and network architectures
Cell membranes, another feature of the cellular infrastructure,
fulﬁll critical roles in cellular signaling. They provide a surface
for macromolecules to assemble on, and barriers to compartmen-
talize certain elements away from others. The movement of pro-
teins within membranes is more restricted than previously
thought as partitioning of membrane segments prevents free diffu-
sion [70]. Many subdomains associated with signaling structures
have been identiﬁed. They can contain protein scaffolds or speciﬁc
lipid compositions [71].
Caveolae, a fairly well-researched class of membrane domains,
are small invaginations of 60–80 nm diameter that are formed
with the help of the caveolin family of integral membrane scaffold
proteins [72]. These structures are thought to be a platform for sig-naling complexes of multiple membrane-associated signaling mol-
ecules that share binding to the caveolin proteins [72–74]. The
complex role of cellular membranes in signaling is also well illus-
trated in the case of the T-cell receptor (TCR) signalosome [10,11].
Before TCR activation, the TCR subunits and a fraction of the mem-
brane-associated scaffold protein LAT are separated into different
clusters in the plasma membrane [75]. Another fraction of LAT is
simultaneously stored in small vesicles, which can interact with
components at the membrane [16]. TCR activation then leads to
the large-scale reorganization at the membrane, in part through
the involvement of the cytoskeleton [76].
New structural features in cells are still being discovered and
we are only beginning to understand functional units like nano-
tubes, purinosomes (multi-enzyme complexes for purine biosyn-
thesis), micro-compartments and the ‘cellular serpents’ of
ﬁlament-forming enzymes [77] in terms of their impact on estab-
lishing the architectures of signaling complexes and networks.
Moreover, at high concentrations, multivalent signaling protein
interactions can, at least in some cases, lead to ‘phase transitions’
in vitro and apparently also in living cells to generate droplet-like
structures [78]. This may contribute to the regulation of protein
activities and can possibly complement other architecture-gener-
ating processes in cells.
6. Origins of cellular complexity and signaling architectures
The evolution of eukaryotic cells and organisms led to a great
increase in structural and signaling complexity. A major contribut-
ing factor to this increase in complexity most likely has been whole
genome duplications, which led to a higher number of protein fam-
ilies and family members, supplied more genetic material for the
genesis of new functions and promoted accelerated evolution in
duplicated genes [79]. In particular, cells in organisms composed
of several or multiple tissues acquired many unique features [80]
and increased robustness and redundancy in old signaling path-
ways [81]. The transition to multi-cellularity and organismal tissue
diversity, favored in an environment where the smaller organisms
get consumed more easily [82], was a further likely contributor to
cell complexity [83]. It also led to an explosion of modular protein
domains [84]. In an excellent review, Bhattacharyya et al. discuss
how the modularity of proteins could have promoted evolutionary
innovation, in particular in signal transduction proteins. Modular-
ity permitted innovation by the recombination of existing ele-
ments and the establishment of novel connectivities between
existing or duplicated proteins. As catalytic function and connec-
tivity were separated, these could be recombined more easily.
Moreover, the division of catalytic function and connectivity into
separate proteins allowed the reuse of catalytic functionalities in
different pathways. The in vivo speciﬁcities of the catalytic do-
mains can be conferred by the combination of catalytic function
with connectivity and regulatory elements on speciﬁc assembly
platforms [84]. This model of separation between catalytic func-
tion and connectivity can, for example, help to understand why
we observe so much promiscuity in the motifs for catalytic en-
zymes like kinases [85], especially when these are studied outside
of their natural contexts.
It is evident that the size of signal transduction protein com-
plexes also increased substantially as eukaryotes became much
more complex. This was again partially enabled by the modularity
of proteins, but also required a substantial ﬂexibility of parts of
proteins’ amino acid chains to easily accommodate architectural
additions and modiﬁcations. Especially in the case of signaling pro-
teins with many transient interactions, structural ‘disorder’ in sub-
stantial segments of the proteins frequently became critical, as will
be discussed in more detail below.
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platforms for multi-molecular signal computation
Assembly platforms for signaling proteins can come inmany ﬂa-
vors. ‘Hubs’ [86] are highly interconnectedwithin the signaling net-
work. Cytoplasmic ‘adapters’, ‘scaffolds’ and ‘largemultisite docking
(LMD) proteins’ co-localize two or more elements of a signaling
pathway or enable complex signal processing. They can also appear
as membrane-associated structures or may even be combined with
catalytic domains, as in the case of the transmembrane receptor ki-
nases [84,87]. The TCR component LAT and the EGF receptor are rep-
resentatives and well-studied examples of two major types of
membrane-associated signal complex assembly sites (see [88] and
[89] for details on their architectures and interactions).
The tumor suppressor p53 is a prototypical example of a com-
plex hub protein ([90,91]; architectural features are discussed in
[92]). After decades of research into p53 new functions and
involvement in different signaling processes are still being discov-
ered. One of its important roles is to act as a transcriptional regu-
lator for the expression of a substantial number of genes, which
will in turn often provide feedback on p53 functions. p53 can also
inhibit cell proliferation and, via many other pathways, contribute
to tumor suppression [91]. It has numerous unstructured protein–
protein interaction epitopes, some of which can adopt different
secondary structures with different binding partners, thus enabling
signiﬁcant binding promiscuity [92–94].
The yeast Ste5 and Pbs2 proteins are prototypical examples of
cytoplasmic scaffolds [95,96] and some aspects of their architec-
ture have readily emerged [97]. Ste5 and its binding partners con-
tribute to a pheromone response pathway that induces a mating
response. Pbs2 and its binding partners contribute to an osmolarity
response pathway. A common binding partner of both proteins is
the Ste11 kinase that can phosphorylate different downstream
effectors. These scaffold proteins, by bringing together the Ste11
kinase and different downstream targets, can add speciﬁcity to
Ste11 function and direct further signaling [98]. For instance, an
engineered fusion-protein of Ste5 and Pbs2 allows redirection of
a pheromone signal to an osmolarity response [99].
Scaffold proteins are relatively rigid structures that coordinate
direct interactions between elements of pathways in a straightfor-
ward, linear manner. By contrast, large multi-site docking (LMD)
proteins like the members of the p130Cas, Gab, Irs/Dok and Frs
families [100–104] allow for a much more integrative processing
of signaling information from different pathways. They interact
in a highly dynamic manner with a larger number of binding part-
ners to integrate information from multiple upstream kinases and
pathways, and they subsequently generate signals that regulate
central biological processes like cell survival, cell proliferation, cell
shape changes and migratory actions.
For example, the multifunctional LMD protein p130Cas (BCAR1)
is phosphorylated as a consequence of signaling by integrins and
several G protein-coupled receptors and recruits a variety of adapt-
ers and further downstream effectors, allowing it to contribute to
cell survival, as well as cell shape change and migration pathways
[101,105]. However, it can also act as an important component of a
pro-apoptotic pathway where it contributes to cell death induction
after its cleavage by proteases [106]. Beyond this, it was proposed
that p130Cas can also act as a primary force sensor for cell stretch-
ing at cell-matrix contact sites [107] resulting in its increased
phosphorylation, and thereby supporting cellular reorientation
after mechanical stimulation [108].
The signiﬁcance of LMD proteins for the integration of signals
sent from distinct receptors and the resulting generation of very
speciﬁc regulatory signals was highlighted again very recently by
the work of Fafalios et al. (2012). They showed that only thecombination of insulin receptor (IR) and c-Met receptor signals,
via the same LMD protein, IRS2 (or IRS1 to a lesser degree), leads
to a robust regulation of glucose levels in liver cells [109]. This
clearly demonstrates that LMD proteins are not merely mediators
of single-receptor signals but that they serve as computational
units for a higher level of signal processing, eventually leading to
enormously complex transcriptional responses, which together
determine cell fate and actions.
A structurally very distinct and presumably somewhat more ri-
gid intracellular ‘meeting point’ that adopts a much clearer de-
ﬁned, seven-bladed beta-propeller fold is the multi-functional
protein Rack1 [110]. It is indeed extremely versatile and can, for
example, serve in different contexts either as a shuttle protein, as
an anchor protein or it can impact on the activities of its binding
partners. One of its many roles seems to be to act as a bridging pro-
tein between insulin family growth factor receptors, like IGFR
(IGF1R) and IR, and their effector proteins, including the Irs pro-
teins, thereby aiding in the assembly of the architectures of signal
transduction computation machines. Unfortunately most of the
ultrastructural details of how Rack1 interacts with the cellular sig-
naling machinery still remain to be deﬁned.
8. Some methods for investigating the compositions and
architectures of signaling complexes and networks
Mass spectrometry has become an important method to inves-
tigate post-translational modiﬁcations and protein–protein inter-
actions in detail and on a global, proteomic scale [111,112]. It is
highly sensitive and can thus be used to investigate many lowly
abundant signaling proteins, provided that highly abundant cell
proteins are sufﬁciently separated or depleted.
Mass spectrometry has also recently helped to unravel the fun-
damental relationship between mRNA expression and protein
expression [113]. Moreover, it can enable researchers to simulta-
neously observe thousands of protein isoforms and numerous
modiﬁcations in a single sample [114].
In the structural analysis of protein complexes, mass spectrom-
etry has equally made great advances over the last years. It can
now be applied to investigate the structure and dynamics of some
protein assemblies [115,116]. This allows the determination of
complex stoichiometries, but it is also useful to deﬁne the subunits
in bigger complexes [117,118] and can even be utilized to study
the kinetics and thermodynamics of complex assembly [118,119].
Mass spectrometry becomes most powerful for structural anal-
yses when combined with other methods [120–122] as no experi-
mental technique can decipher the full spectrum of spatial and
temporal information that is necessary for a complete character-
ization of macromolecular assemblies [123].
Cryo-electron microscopy (cryo-EM), that is the observation of
snap-frozen samples under a transmission electron microscope,
is a particularly useful method to move into the realm of directly
observable structures as it allows observation at near-atomic reso-
lution. Resolutions in the range of 1 nm have been achieved for lar-
ger, symmetrical particles [124] and, at least in theory, even much
higher resolution should be possible [125]. Cryo-electron tomogra-
phy is a modiﬁcation of cryo-EM where whole cells or sections are
snap-frozen and imaged iteratively while being tilted incremen-
tally. This permits studies of molecular assemblies in situ in 3D
[126–128].
Hybrid approaches using mass spectrometry and cryo-EM have
been successfully applied in determining the architecture of the
26S proteasome holocomplex [129], elucidating the intricacies of
protein translation [130].
New technological developments in X-ray crystallography, such
as advances in the application of hard X-ray free-electron lasers
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ing proteins and protein complexes (i.e. those which produce only
nanocrystals) to be more easily determined in the future [131].
Additionally, new computational tools have recently become avail-
able that help with the integration of data from different experi-
mental approaches (i.e. biophysical methods) into one model
[132,133].
The often rather transiently assembled signaling complexes
pose additional challenges compared to ribosomes, proteasomes
and similar molecular machines. However, through (i) careful step-
wise biochemical assembly of signalosomes from highly puriﬁed
components for their biophysical and functional analysis, (ii) the
combined application of currently available methods, and (iii) the
(presumed) development of additional high-resolution imaging
techniques in the coming years, the emergence of important con-
cepts regarding the architectures and mechanisms of action of
multi-protein signal computation machines is expected to come ﬁ-
nally into our reach.
9. Disordered proteins and protein segments are crucial for
cellular signaling processes
Classical protein research has often focused on functional pro-
tein domains with well-folded structures. However, it has been rec-
ognized for some years now that surprisinglymany proteins appear
to have at least in part no apparent deﬁned structure [134–137].
These unstructured regions are often essential for protein function.
A large number of algorithms have been developed to predict re-
gions of disorder from the amino acid sequence of a protein, com-
monly based on the initial ﬁnding that low hydrophobicity and
high net charge is a deﬁning feature of disordered proteins
[138,139]. In mammals, 75% of signaling proteins and 50% of all cel-
lular proteins are predicted to have regions with disorder of more
than 30 amino acids in length. 25% of all proteins may even be com-
pletely disordered [135]. Not surprisingly, considering the vast
number of presumably disordered proteins, some of these have
been implicated in cancer development [138] as well as in neurode-
generative and cardiovascular diseases [140]. As disorder may lead
to protein aggregation, a key problem in many neurodegenerative
diseases, it was expected that disordered proteins may be subject
to tight regulation. However, the results were not as clear-cut as
previously thought [134]. On one hand, unstructured proteins were
reported to be tightly regulated [141], but on the other hand studies
found only a weak association of disorder with a shorter protein
half-life [134,142]. Stabilization by inter- as well as intra-molecular
interactions have been suggested as mechanisms to protect disor-
dered proteins from early degradation [143,144] but other, less
obvious features, for example related to their amino acid composi-
tion, or whether or not they have a structured C-terminus (M.M.
Babu, personal communication), may also contribute.
Disordered regions appear to feature particularly strongly in
signaling proteins [145]. They often contain short (or eukaryotic)
linear motifs (SLiMs, or ELMs; [146]) that allow docking of protein
domains [147,148] and are sites of post-translational modiﬁcation
[149]. Protein disorder may also be a characteristic feature of
receptors with recognition and signaling functions distributed be-
tween separate protein chains [150]. Functionally important disor-
dered epitopes, albeit sometimes very short, are presumably often
conserved throughout evolution and can thus be detected with bio-
informatics tools [151]. This discovery of novel putative functional
motifs can help to then experimentally deﬁne previously unrecog-
nized architectural elements in protein chains and complexes.
Disordered proteins are very diverse in their propensities to as-
sume more deﬁned conformations on their own or upon interac-
tion with other proteins. Some proteins maintain disorder undercrowded conditions [152], whereas others may gain structure
[153,154]. Some disordered regions can acquire a ﬁxed conforma-
tion upon binding [155–157] while others remain disordered
[158]. Disorder also allows some very unusual interactions; the
yeast ubiquitin ligase San1, for example, recognizes misfolded sub-
strates [159] and the CDK inhibitor Sic1 interacts with a single site
on Cdc4 via multiple dispersed phosphorylation sites [158]. The
hub proteins already mentioned frequently contain disordered re-
gions [160] that are used to interact with a variety of partners [93].
Research into disordered proteins, although still limited by a
lack of easy-to-use methods that allow the speedy recognition of
different types of disorder or their functional classiﬁcation, appears
to be currently gaining momentum and we expect that new details
on how disorder can be used in various signaling contexts will also
lead to a better understanding of signaling complex architectures.
10. Disorder is presumed to be an important prerequisite for
efﬁcient signal computation in large multi-site docking
proteins
A common feature of large multi-site docking (LMD) proteins of
the Gab, Irs, Frs, Dok and p130Cas families is their composition of
one or two well-structured N-terminal domains followed by long
disordered ‘ﬂoppy tail’ regions [143,161]. How such ‘snake-like’
appearances can effectively serve to mediate complex signal com-
putations, which are attributed to multi-protein complexes assem-
bled on these ‘platform’ proteins based on functional studies, has
been puzzling us for some years. Upon closer inspection of the hu-
man proteome with domain recognition programs about 70 pro-
teins with a similar design have been detected [143].
Recent and somewhat serendipitous ﬁndings now indicate that
Gab proteins and its ‘look-alikes’ could actually be much ‘better’
organized than initially thought. For Gab1 (Fig. 2) the ﬁrst evidence
has emerged that the lipid binding pocket of its N-terminal pleck-
strin homology (PH) domain is regulated by a speciﬁc epitope dis-
tant by over 400 amino acids in its disordered protein tail [162].
Surprisingly, upon closer inspection of this Gab1 PH domain – tail
interaction, a number of additional tail regions showed binding to
this domain in vitro [143]. Some of these regions overlap with al-
ready known protein interaction sites [161,163], but others are no-
vel and beg further studies.
The detection of these interaction sites, which appear to sepa-
rate functionally clustered SH2 docking motifs, has led to the pro-
posal of a new conceptual framework for the architectures of
disordered signal protein complex assembly platforms (i.e. LMD
proteins) with folded N-terminal domains: the N-terminal folding
nucleation (NFN) hypothesis [143] (Fig. 2). According to this
hypothesis, the repeated folding back of a largely disordered pro-
tein chain of several hundred amino acids onto a well-structured
N-terminal domain would generate several functionally dedicated
loops. Such a model provides an intriguing explanation of how Gab
family and other similarly composed LMD proteins can effectively
assemble multi-protein complexes to compute multiple incoming
signals and subsequently coordinate functionally interdependent
downstream signals. This occurs simply by assembling pathway-
speciﬁc sub-complexes in distinct tail loops that hover around
the N-terminal fold and by then bringing these loops together to
cross-talk [143]. Experimental validation of this architectural
hypothesis is urgently required but not entirely trivial.
The conformations of disordered proteins are difﬁcult to study
with X-ray crystallography and so NMR has been applied fre-
quently to study their structure in vitro. The development of in-cell
NMR in recent years could help in future to better understand their
structure in vivo [164]. In-cell NMR requires the labeling of pro-
teins with an NMR-active isotope and their delivery into the cell.
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mination of complete protein structures [165]. In eukaryotic cells
protein delivery is more difﬁcult. Microinjection has been used to
deliver the disordered tau protein into Xenopus oocytes where it
was found to maintain its disorder even under crowded conditions
[166]. In other studies researchers used cell-penetrating peptides
[167] or a pore complex [168] to deliver labeled proteins into hu-
man cells. Until recently, relatively high concentrations of labeled
protein were required for such studies, however, newer, more ra-
pid NMR methods may make it now possible to study proteins at
more physiological levels [164]. Small angle X-ray scattering
(SAXS) [169], the cryo-EM methods already discussed, as well as
high-speed atomic force microscopy (AFM) [170] should prove
useful for exploring the molecular organization of cellular signal-
ing complex architectures. It will be exciting to see these advanced
imaging technologies applied to their full potential on the signaling
machinery of cells in the near future.
11. Perspective
We propose that the degrees of architectural and infrastructural
sophistication which cells display while accomplishing their sig-
naling tasks (and many other complex tasks) are currently still
much under-appreciated and that this concept should guide us to
careful, and possibly less invasive experimentation, as well as
inﬂuence our attempts of data interpretation. In this dawning
age of ultra-fast data generation at massive scales we need to con-
sider carefully which concepts will enable us to conduct better
experiments with the potentially powerful tools we now have
and how we can best obtain meaningful information from ever-
growing piles of puzzle pieces. It is time to put them together.
Without a doubt, dealing with such multi-dimensional puzzles
(4D or greater: space and time, but also cell type, disease state etc.)
of great complexity will also require sophisticated ways of repre-
senting the detailed molecular information on several levels of
magniﬁcation, in order to make it accessible to more general audi-
ences. These methods may not differ too much from the technolo-
gies used in ‘3D’ ﬁlms, and almost certainly will be facilitated by
computer graphics and hierarchical visualization systems to repre-
sent dynamic molecular behavior and interactions, integrating cell
biological, structural and biophysical knowledge. Whether the
same information can be adequately translated to the 2D printed
page is unclear, given the oversimpliﬁcation of line drawings. Is
there still an appetite for dumpling soup?
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Note added in proof
For modeling purposes some cellular processes can be consid-
ered to occur in only one or two dimensions to simplify computa-
tion and to make the model more easily understandable. However,
if understanding the geometry of a process is essential, a 3D or 4D
model becomes necessary [174]. Computational approaches that
take the geometry of cellular processes into account are becoming
increasingly available to biologists [175] and have been successfullyapplied to model, for example, receptor-mediated cellular adhesion
and MAPK activation in yeast [176].
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